Variant report
Variant | nsv881480 |
---|---|
Chromosome Location | chr5:29566495-29631637 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:132)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr5:29587962-29588174 | Hela-S3 | cervix: | n/a | n/a |
2 | CCNT2 | chr5:29568109-29568475 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr5:29567799-29568536 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr5:29597920-29598079 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr5:29630539-29630789 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr5:29568089-29568567 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr5:29587991-29588728 | Hela-S3 | cervix: | n/a | n/a |
8 | CEBPB | chr5:29614349-29614730 | Hela-S3 | cervix: | n/a | n/a |
9 | CEBPD | chr5:29568086-29568544 | K562 | blood: | n/a | n/a |
10 | CEBPD | chr5:29568101-29568557 | K562 | blood: | n/a | n/a |
11 | CTCF | chr5:29604300-29604341 | Kidney_OC | kidney: | n/a | n/a |
12 | CTCF | chr5:29600742-29600770 | ProgFib | skin: | n/a | n/a |
13 | CTCF | chr5:29597260-29597410 | HCPEpiC | choroid plexus: | n/a | n/a |
14 | CUX1 | chr5:29567485-29567571 | K562 | blood: | n/a | n/a |
15 | E2F4 | chr5:29616472-29616776 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | EP300 | chr5:29614493-29614560 | GM12878 | blood: | n/a | n/a |
17 | EP300 | chr5:29614431-29614795 | Hela-S3 | cervix: | n/a | n/a |
18 | EP300 | chr5:29617734-29617895 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr5:29587974-29588741 | Hela-S3 | cervix: | n/a | n/a |
20 | EP300 | chr5:29595145-29595190 | K562 | blood: | n/a | n/a |
21 | EP300 | chr5:29590439-29590517 | K562 | blood: | n/a | n/a |
22 | EP300 | chr5:29606680-29606775 | K562 | blood: | n/a | n/a |
23 | EP300 | chr5:29568019-29568510 | K562 | blood: | n/a | n/a |
24 | FOS | chr5:29588026-29588636 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOS | chr5:29587998-29588768 | Hela-S3 | cervix: | n/a | n/a |
26 | FOS | chr5:29614318-29614779 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOS | chr5:29566955-29567155 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | FOS | chr5:29588032-29588235 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | FOS | chr5:29614369-29614731 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | FOS | chr5:29614335-29614781 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | FOS | chr5:29614333-29614724 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr5:29588092-29588292 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOSL2 | chr5:29587980-29588275 | MCF-7 | breast: | n/a | n/a |
34 | GABPA | chr5:29568136-29568439 | K562 | blood: | n/a | n/a |
35 | GATA1 | chr5:29567856-29568674 | PBDE | blood: | n/a | chr5:29568304-29568320 chr5:29568215-29568226 chr5:29568308-29568317 chr5:29568307-29568317 chr5:29568306-29568318 |
36 | GATA1 | chr5:29567740-29568719 | K562 | blood: | n/a | chr5:29568304-29568320 chr5:29568215-29568226 chr5:29568308-29568317 chr5:29568307-29568317 chr5:29568306-29568318 |
37 | GATA2 | chr5:29568062-29568517 | K562 | blood: | n/a | chr5:29568304-29568320 chr5:29568215-29568226 chr5:29568308-29568317 chr5:29568307-29568317 chr5:29568306-29568318 |
38 | GATA3 | chr5:29587914-29588292 | MCF-7 | breast: | n/a | n/a |
39 | HDAC2 | chr5:29568186-29568398 | K562 | blood: | n/a | n/a |
40 | HMGN3 | chr5:29568149-29568472 | K562 | blood: | n/a | n/a |
41 | IRF1 | chr5:29568301-29568381 | K562 | blood: | n/a | n/a |
42 | IRF1 | chr5:29568216-29568498 | K562 | blood: | n/a | n/a |
43 | JUN | chr5:29567665-29567678 | HepG2 | liver: | n/a | n/a |
44 | JUN | chr5:29570495-29570505 | HepG2 | liver: | n/a | n/a |
45 | JUN | chr5:29614461-29614561 | HepG2 | liver: | n/a | chr5:29614504-29614517 |
46 | JUN | chr5:29567055-29567227 | K562 | blood: | n/a | n/a |
47 | JUN | chr5:29587909-29588757 | Hela-S3 | cervix: | n/a | n/a |
48 | JUN | chr5:29588921-29589044 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | JUND | chr5:29587921-29588732 | Hela-S3 | cervix: | n/a | n/a |
50 | JUND | chr5:29625360-29625551 | HepG2 | liver: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:29623807..29626845-chr5:29627046..29630345,3 | MCF-7 | breast: | |
2 | chr5:29620035..29622604-chr5:29624083..29625819,2 | K562 | blood: | |
3 | chr5:29615746..29618032-chr5:29623108..29625004,2 | K562 | blood: | |
4 | chr5:29615746..29618032-chr5:29623108..29625004,2 | K562 | blood: | |
5 | chr16:89785981..89788099-chr5:29571782..29574694,2 | MCF-7 | breast: | |
6 | chr5:29623807..29626845-chr5:29627046..29630345,3 | MCF-7 | breast: | |
7 | chr16:27487589..27488219-chr5:29570534..29571280,2 | MCF-7 | breast: | |
8 | chr5:29620035..29622604-chr5:29624083..29625819,2 | K562 | blood: | |
9 | chr5:29628564..29631486-chr5:29634106..29636111,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
UBL5P1 | TF binding region |
ENSG00000158805 | chromatin interactions |
ENSG00000075399 | chromatin interactions |
ENSG00000077235 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535641692 | chr5:29566806-29566807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557220450 | chr5:29566810-29566811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546709882 | chr5:29566813-29566814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184167398 | chr5:29566851-29566852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539124693 | chr5:29566917-29566918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73087319 | chr5:29566927-29566928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572701425 | chr5:29566928-29566929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540230244 | chr5:29566948-29566949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114767246 | chr5:29566975-29566976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574825138 | chr5:29566976-29566977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528886757 | chr5:29566983-29566984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548924340 | chr5:29567051-29567052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs143418296 | chr5:29567052-29567053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188715972 | chr5:29567118-29567119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545931463 | chr5:29567147-29567148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs191940464 | chr5:29567158-29567159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112829432 | chr5:29567160-29567161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528465454 | chr5:29567195-29567196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547063148 | chr5:29567244-29567245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538121780 | chr5:29567295-29567296 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557956449 | chr5:29567319-29567320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571492192 | chr5:29567347-29567348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529239350 | chr5:29567401-29567402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550906939 | chr5:29567404-29567405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183237286 | chr5:29567496-29567497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370268746 | chr5:29567501-29567502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573719291 | chr5:29567503-29567504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534066466 | chr5:29567560-29567561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551147239 | chr5:29567569-29567570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566611368 | chr5:29567603-29567604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187043789 | chr5:29567627-29567628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554980379 | chr5:29567665-29567666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573319711 | chr5:29567667-29567668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545548347 | chr5:29567684-29567685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557236084 | chr5:29567708-29567709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575709036 | chr5:29567753-29567754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79479006 | chr5:29567754-29567755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10069250 | chr5:29567773-29567774 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs191845143 | chr5:29567788-29567789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111388818 | chr5:29567811-29567812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529228199 | chr5:29567814-29567815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562027549 | chr5:29567830-29567831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139339303 | chr5:29567855-29567856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550845461 | chr5:29567878-29567879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73087321 | chr5:29567884-29567885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183973112 | chr5:29567886-29567887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs551582636 | chr5:29567893-29567894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs566431629 | chr5:29567979-29567980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111713005 | chr5:29568009-29568010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533610860 | chr5:29568045-29568046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29566800-29567200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr5:29567000-29567200 | Enhancers | Primary hematopoietic stem cells | blood |
3 | chr5:29567000-29568200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:29567200-29567600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr5:29567400-29568400 | Weak transcription | Primary hematopoietic stem cells | blood |
6 | chr5:29567600-29569800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr5:29568200-29568800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr5:29568400-29568800 | Enhancers | Primary hematopoietic stem cells | blood |
9 | chr5:29568800-29569200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr5:29569200-29569400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr5:29569400-29570200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr5:29569800-29570800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr5:29570200-29571200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr5:29570800-29572400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr5:29571200-29571400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
16 | chr5:29571400-29571600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr5:29571600-29571800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr5:29571800-29572000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr5:29572000-29572200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr5:29587200-29589400 | Enhancers | Hela-S3 | cervix |
21 | chr5:29602800-29603600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr5:29613600-29614200 | Enhancers | Hela-S3 | cervix |
23 | chr5:29614200-29614600 | Weak transcription | Hela-S3 | cervix |
24 | chr5:29614600-29615200 | Enhancers | Hela-S3 | cervix |